Opaleye Management as of March 31, 2021
Portfolio Holdings for Opaleye Management
Opaleye Management holds 58 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 15.6 | $106M | 6.5M | 16.41 | |
| Chimerix (CMRX) | 6.4 | $43M | 4.5M | 9.64 | |
| Protara Therapeutics Com Stk (TARA) | 5.9 | $40M | 2.6M | 15.74 | |
| Bridgebio Pharma (BBIO) | 5.3 | $36M | 584k | 61.60 | |
| Codexis (CDXS) | 4.7 | $32M | 1.4M | 22.89 | |
| Eton Pharmaceuticals (ETON) | 4.3 | $30M | 4.0M | 7.32 | |
| Macrogenics (MGNX) | 3.1 | $21M | 666k | 31.85 | |
| Tracon Pharmaceuticals Com New | 3.0 | $21M | 2.5M | 8.23 | |
| Harrow Health (HROW) | 3.0 | $21M | 3.1M | 6.75 | |
| Celldex Therapeutics Com New (CLDX) | 3.0 | $20M | 985k | 20.60 | |
| Xoma Corp Del Com New (XOMA) | 2.6 | $18M | 438k | 40.81 | |
| Stereotaxis Com New (STXS) | 2.5 | $17M | 2.5M | 6.72 | |
| Neoleukin Therapeutics | 2.2 | $15M | 1.2M | 12.31 | |
| Fortress Biotech | 2.0 | $14M | 3.9M | 3.53 | |
| Cytokinetics Com New (CYTK) | 2.0 | $14M | 580k | 23.26 | |
| Autolus Therapeutics Sponsored Ads (AUTL) | 1.8 | $12M | 2.1M | 5.73 | |
| Gemini Therapeutics | 1.6 | $11M | 811k | 13.55 | |
| Deciphera Pharmaceuticals | 1.5 | $10M | 222k | 44.84 | |
| Seres Therapeutics | 1.4 | $9.8M | 300k | 32.68 | |
| Keros Therapeutics (KROS) | 1.4 | $9.7M | 158k | 61.55 | |
| Checkpoint Therapeutics | 1.3 | $9.2M | 2.9M | 3.14 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 1.3 | $8.6M | 1.3M | 6.61 | |
| Essa Pharma Com New (EPIX) | 1.2 | $8.3M | 284k | 29.05 | |
| Acutus Medical (AFIB) | 1.2 | $8.2M | 615k | 13.37 | |
| Adamas Pharmaceuticals | 1.2 | $8.0M | 1.7M | 4.80 | |
| Cerecor | 1.2 | $7.9M | 2.6M | 3.02 | |
| Sutro Biopharma (STRO) | 1.1 | $7.8M | 342k | 22.76 | |
| Protagonist Therapeutics (PTGX) | 1.1 | $7.7M | 297k | 25.90 | |
| Immunovant (IMVT) | 1.1 | $7.5M | 467k | 16.04 | |
| Vaxcyte (PCVX) | 1.0 | $7.1M | 358k | 19.75 | |
| Sanara Medtech (SMTI) | 1.0 | $7.0M | 225k | 31.15 | |
| Catalyst Biosciences Com New | 0.9 | $6.3M | 1.3M | 5.04 | |
| Aveo Biosciences Com New | 0.9 | $6.1M | 835k | 7.32 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.9 | $5.9M | 321k | 18.51 | |
| Verastem | 0.8 | $5.7M | 2.3M | 2.47 | |
| Tela Bio (TELA) | 0.8 | $5.4M | 365k | 14.90 | |
| Mei Pharma Com New | 0.8 | $5.3M | 1.6M | 3.43 | |
| Cardiff Oncology (CRDF) | 0.8 | $5.3M | 576k | 9.26 | |
| Sio Gene Therapies | 0.8 | $5.2M | 2.0M | 2.61 | |
| Aptose Biosciences Com New | 0.8 | $5.2M | 872k | 5.97 | |
| Myovant Sciences | 0.8 | $5.1M | 250k | 20.58 | |
| Fibrogen | 0.7 | $5.1M | 147k | 34.71 | |
| Lumos Pharma | 0.6 | $4.4M | 377k | 11.70 | |
| Kezar Life Sciences | 0.6 | $4.2M | 711k | 5.96 | |
| Optinose | 0.4 | $3.0M | 826k | 3.69 | |
| Highcape Capital Acquisition Corp Com Cl A | 0.4 | $2.9M | 241k | 11.92 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.4 | $2.9M | 188k | 15.28 | |
| Edap Tms Sa Sponsored Adr (EDAP) | 0.4 | $2.9M | 341k | 8.40 | |
| Sierra Oncology Com New | 0.4 | $2.6M | 151k | 17.23 | |
| Biohaven Pharmaceutical Holding | 0.3 | $1.7M | 25k | 68.36 | |
| Alpine Immune Sciences | 0.2 | $1.7M | 157k | 10.60 | |
| Aerpio Pharmaceuticals | 0.2 | $1.3M | 1.0M | 1.29 | |
| Ayala Pharmaceuticals Incorporated | 0.2 | $1.2M | 109k | 10.91 | |
| Contrafect Corp Com New | 0.2 | $1.2M | 244k | 4.80 | |
| Magenta Therapeutics | 0.2 | $1.0M | 88k | 11.84 | |
| Viracta Therapeutics (VIRX) | 0.1 | $958k | 104k | 9.25 | |
| Leap Therapeutics | 0.1 | $737k | 388k | 1.90 | |
| Biolinerx Sponsored Ads | 0.0 | $47k | 17k | 2.82 |
